scholarly article | Q13442814 |
P356 | DOI | 10.1097/00007691-199806000-00007 |
P698 | PubMed publication ID | 9631924 |
P2093 | author name string | Levine M | |
Keown PA | |||
Kovarik JM | |||
Mueller EA | |||
Primmett DR | |||
P433 | issue | 3 | |
P921 | main subject | cyclosporine | Q367700 |
P304 | page(s) | 276-283 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | Therapeutic Drug Monitoring | Q15724567 |
P1476 | title | Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure. | |
P478 | volume | 20 |
Q43705339 | A limited sampling strategy for cyclosporine area under the curve monitoring in lung transplant recipients. |
Q36831051 | Calcineurin inhibitors in pediatric renal transplant recipients |
Q77369580 | Cyclosporine A: peak or trough level monitoring in renal transplant recipients? |
Q45046062 | Cyclosporine levels at 2 hours after dose and body mass index in relation to graft function in renal transplant patients treated with azathioprine or mycophenolate mofetil. |
Q44051279 | Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation |
Q35711382 | Evolution of the therapeutic drug monitoring of cyclosporine |
Q35980234 | Immunosuppressant drug monitoring: is the laboratory meeting clinical expectations? |
Q36029868 | Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome |
Q28244228 | Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients |
Q43875084 | Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants |
Q33937533 | Methods for clinical monitoring of cyclosporin in transplant patients. |
Q35154212 | Nano composite emulsion for sustained drug release and improved bioavailability |
Q43828393 | Neoral drug monitoring in stable kidney allotransplant recipients: C(0) versus C(2). |
Q73756670 | New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients |
Q37781449 | Novel Strategies for Immune Monitoring in Kidney Transplant Recipients |
Q43828405 | Optimization of cyclosporine therapy in the Neoral era: abbreviated AUC, single blood sampling? |
Q54475479 | Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant. |
Q83220048 | Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation |
Q73314640 | Pharmacokinetics of abbreviated AUC of cyclosporine in renal allograft recipients in a Pakistani population |
Q44051282 | Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis |
Q33345496 | Review of the proliferation inhibitor everolimus |
Q57605884 | Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation |
Q36742534 | The CARI guidelines. Calcineurin inhibitors in renal transplantation: therapeutic drug monitoring |
Q44187095 | Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children |
Q35710903 | Use of cyclosporine in renal transplantation |
Q51673782 | Validation of Sparse Sampling Strategies to Estimate Cyclosporine A Area Under the Concentration-Time Curve Using Either a Specific Radioimmunoassay or High-Performance Liquid Chromography Method |
Search more.